The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards

Digestive and Liver Disease

Volumn 36, Issue 8, 2004, Pages 539-546

  Gentilini, P ^a   Bernardi, M ^b   Bolondi, L ^b   Crazi A ^c   Gasbarrini, G ^d   Ideo, G ^e   Laffi, G ^a   La Villa, G ^a   Salerno, F ^f   Ventura, E ^g   Pulazzini, A ^h   Segantini, L ^h   Romanelli, R G ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e S Giuseppe Hospital   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^h Delphi Method Consultant Think Tank   (Italy)

Author keywords

Albumin; Ascites; Cirrhosis; Delphi method

Indexed keywords

ALBUMIN; ALBUMINOID;

ARTICLE; ASCITES; CONSENSUS; DRUG USE; HOME CARE; HOSPITALIZATION; HUMAN; ITALY; LIVER CIRRHOSIS; MEDICAL SPECIALIST; OUTPATIENT CARE; PHYSICIAN; PRESCRIPTION; QUESTIONNAIRE; SOCIOECONOMICS; STANDARDIZATION; WELLBEING; DELPHI STUDY; REIMBURSEMENT; STANDARD;

ALBUMINS; ASCITES; DELPHI TECHNIQUE; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; ITALY; LIVER CIRRHOSIS; PRESCRIPTIONS, DRUG;

EID: 4644292785     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2004.03.014     Document Type: Article

References (21)

1. Ministero della Sanità. Dipartimento per la valutazione dei farmaci e la farmacovigilanza. Note CUF Roma, 1999: http://www.sanita.it/farmaci.
2. Ministero della Sanità. Decreto ministeriale n. 4 del 22 dicembre 2000. Revisione delle note riportate nel provvedimento 30 dicembre 1993 di riclassificazione dei medicinali e successive modificazioni. Supplemento ordinario alla Gazzetta Ufficiale n. 7 del 10 gennaio 2001. serie generale.
3. Vermeulen Jr LC, Ratko TA, Erstad BL, Brecher ME, Matuszewski KA. A paradigm for consensus - the University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. Arch Intern Med 1995;155:373-9.
4. Sackman H. Delphi critique. Lexington, MA: Lexington Books; 1975.
5. Helmer O. Looking forward. A guide to future research. Beverly Hills: Sage; 1983.
6. Linstone H, Turoff M, editors. The Delphi method. Techniques and applications. Reading, MA: Addision Wesley Publishing Company Inc.; 1975.
7. Masini E. Why future studies? London: Grey Seal; 1994.
8. Adler M, Ziglio E, editors. Gazing into the Oracle: the Delphi method and its application to social policy and public health. London: Jessica Kingsley Publishers; 1996.
9. Arroyo V, Colmenero J. Use of albumin in the management of patients with decompensated cirrhosis. An independent verdict. Dig Liver Dis 2003;35:668-72.
10. Gines A, Fernandez-Esparrach G, Monescillo A, Vila C, Domenech E, Abecasis R, et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 1996;111:1002-10.
11. Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-Del-Arbol L, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999;341:40340-9.
12. Guevara M, Gines P, Fernandez-Esparrach G, Sort P, Salmeron JM, Jimenez W, et al. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology 1998;27:35-41.
13. Gentilini P, Casini-Raggi V, Di Forte G, Romanelli RG, Buzzelli G, Pinzani M, et al. Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. J Hepatol 1999;30:639-45.
14. Laffi G, Gentilini P, Romanelli RG, La Villa G. Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour. Dig Liver Dis 2003;35:660-3.
15. Burroughs AK. Is the use of albumin of value in the treatment of ascites in cirrhosis? The case not so in favour, or is there an alternative? Dig Liver Dis 2003;35:664-7.
16. Uriz J, Ginès P, Cárdenas A, Sort P, Jiménez W, Salmerón JM, et al. Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. J Hepatol 2000; 33:43-8.
17. Angeli P, Albino G, Carraro P, Dalla Pria M, Merkel C, Caregaro L, et al. Cirrhosis and muscle cramps: evidence of a causal relationship. Hepatology 1996;23:264-73.
18. Angeli P, Volpin R, Gerunda G, Craighero R, Roner P, Merenda R, et al. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology 1999;29:1690-7.
19. Ortega R, Gines P, Uriz J, Cardenas A, Calahorra B, De Las Heras D, et al. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology 2002;36:941-8.
20. Arroyo V, Gines P, Gerbes AL, Dudley F, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996;23:164-76.
21. Fattore G, Lazzaro C. Analisi dei costi della somministrazione di albumina umana nel paziente cirrotico con ascite. MECOSAN (Management ed economia sanitaria) 2002;40:53-65.